RIVAROXABAN

250mg
500mg
tablets

Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

1,5mg coated tablets

4mg
8mg
20mg
tablets

0,1mg tablets

2,5mg/1,25mg
2,5mg/2,5mg
5mg/2,5mg
5mg/5mg
10mg/5mg
10mg/10mg

5mg/100mg; 10mg/100mg; 20mg/100mg capsules

Treatment of myelofibrosis (intermediate/high-risk), polycythaemia vera (resistant/intolerant to hydroxyurea), and steroid-refractory acute or chronic Graft-versus-Host Disease.

 25mg; 50mg; 100mg coated tablets (25mg; 50mg also available as OTC)

25mg; 50mg; 100mg coated tablets

50mg/500mg
50mg/1000mg
100mg/1000mg
ER tablets

6mg/0,4mg ER tablets

Adamd`s Product Portfolio

Davipharm is a member of the Adamed group. Produced in Vietnam with EU GMP standards. The export products' list to non-stringent & stringent markets. Contact us

Presentation

The history of Adamed is about responding to thekey challenges of modern medicine. This is both ourmission and the direction we have consistently takensince 1986. Every day, we work with numerousscientists on innovative research projects aimed atimproving existing therapies and promoting diseaseprevention and a healthy lifestyle. To achieve ourgoals, we employ the best specialists in the countryand collaborate with leading scientific centres andinstitutions, while employing state-of-the-art technologiesin all areas of our operations.All this makes Adamed a leader in the next-generationpharmaceutical market in Poland. Our productsare available in dozens of markets all over theworld. Even with this success, we have no intentionof resting on our laurels. We continue to evolve andto search for inspiration and unconventional solutions.We encourage you to learn more about AdamedPharma – the place where Polish innovation begins.

This is where Polish innovation begins